SCHEMBL10090172

SCHEMBL10090172

COCCCn1c2ccccc2c2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.64
CNR2 P34972 1/20 0.56
PTGER4 P35408 1/20 0.55
FABP4 P15090 2/20 0.51
FABP5 Q01469 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
GRIN1 Q05586 7/20 0.50
GRIN2A Q12879 7/20 0.50
GRIN2B Q13224 7/20 0.50
MAOA P21397 5/20 0.50
MAOB P27338 5/20 0.50
ACHE P22303 2/20 0.50
GAA P10253 1/20 0.49
PLK1 P53350 1/20 0.49
SMPD1 P17405 1/20 0.49
SIGMAR1 Q99720 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29941758 1.00 ALDH1A1 (0.64) ALDH1A1CNR2PTGER4FABP4FABP5
SCHEMBL1149879 0.88 PTGER4 (0.67) ALDH1A1CNR2PTGER4FABP4FABP5
SCHEMBL27772057 0.86 SMPD1 (0.52) ALDH1A1CNR2PTGER4MEN1KMT2A
SCHEMBL3943747 0.84 CNR2 (0.51) ALDH1A1CNR2PTGER4FABP4FABP5
SCHEMBL30294930 0.81 MEN1 (0.70) ALDH1A1PTGER4FABP4FABP5MEN1
SCHEMBL30716978 0.81 MEN1 (0.70) ALDH1A1PTGER4FABP4FABP5MEN1
SCHEMBL13387568 0.81 MEN1 (0.70) ALDH1A1PTGER4FABP4FABP5MEN1
SCHEMBL14578721 0.81 MEN1 (0.70) ALDH1A1PTGER4FABP4FABP5MEN1
SCHEMBL4552166 0.81 FABP4 (0.64) ALDH1A1FABP4FABP5MEN1KMT2A
SCHEMBL4552481 0.81 FABP4 (0.68) FABP4FABP5GRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855458-B1 CARBAZOLE-CONTAINING SULFONAMIDES AS CRYPTOCHROME MODULATORS RESET THERAPEUTICS INC (US) 2018-08-08 EP disclosed
US-8148541-B2 Rhodanine derivatives, a process for the preparation thereof and pharmaceutical composition containing the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2012-04-03 US disclosed
US-20090042872-A1 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042872-A1 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same PTPRR, PTPRG, PTPRS ALDH1A1 2660/4885CNR2 3622/4885PTGER4 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.